Keyphrases
Pertrochanteric Femoral Fractures
93%
Universal Neonatal Hearing Screening
93%
Selective Screening
93%
Childhood Deafness
93%
Opioid Agonist Treatment
93%
Blood Loss
93%
Prospective Observational Study
93%
Opioid Addiction
93%
Hearing Impairment
93%
Deafness
93%
Long-term Efficacy
62%
Opportunistic Screening
62%
Neonatal Screening
62%
Embase
37%
Intraoperative Blood Loss
37%
MEDLINE
37%
Fetal Hypoxia
31%
Newborn Hearing Screening Program
31%
Degree of Hearing Impairment
31%
Assessment Agency
31%
Universal Newborn Hearing Screening
31%
Cochrane Library
31%
Early Treatment
31%
Child Development
31%
Randomized Controlled Trial
31%
Issue 2
31%
High Incidence
31%
Risk Factors
31%
Screening Test
31%
Low Birth Weight
31%
Clinical Practice Guidelines
31%
High-risk Population
31%
Number of Factors
31%
Review Authors
31%
Health Technology Assessment
31%
High Sensitivity
31%
Treatment Programs
31%
Search Results
31%
Prematurity
31%
High Specificity
31%
Early Detection System
31%
Jaundice
31%
Preterm Neonates
31%
Cochrane Central Register of Controlled Trials
31%
Inclusion Criteria
31%
Risk Screening
31%
Treatment Retention
25%
Dynamic Hip Screw
18%
Risk-benefit Analysis
18%
Pertrochanteric Fracture
18%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Opiate Agonist
93%
Opiate Addiction
93%
Hearing Impairment
93%
Femur Pertrochanteric Fracture
93%
Bleeding
93%
Postoperative Hemorrhage
15%
Disease
12%
Low Birth Weight
11%
Jaundice
11%
Hypoxia
11%
Prematurity
11%
Randomized Controlled Trial
11%
Opiate
6%
Nursing and Health Professions
Hearing Impairment
93%
Auditory Screening
93%
Newborn Screening
23%
Cochrane Library
23%
Screening
11%
Hypoxia
11%
Prematurity
11%
Neonates
11%
Low Birth Weight
11%
Biomedical Technology Assessment
11%
Screening Test
11%
Jaundice
11%
High Risk Population
11%
Sensitivity and Specificity
11%
Clinical Guideline
11%
